Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based Study

Table 2

Lifetime and active prevalence in the three representative regions.

	Total identified cases	Calculated mean crude prevalence per 1,000 people (95% CI)	Estimated cases in confirmation phase	Estimated mean crude prevalence per 1,000 people (95% CI)	Calculated mean overall prevalence, adjusted by age and sex per 1,000 people (95% CI)	Estimated mean overall prevalence, adjusted by age and sex per 1,000 people, corrected for dropouts; (95% CI)
Zaragoza health district	7	12.94; (5.2–26.7)	8.71	16.11; (7.6–31.6)	12.30 (7.5–18.4)	14.87 (9.8–21.9)
Almería health district	7	11.66; (4.7–25)	7.52	12.54; (5.8–26.3)
Seville health district	8	13.33; (5.8–26.3)	10.90	18.18; (9.2–32.8)
Lifetime prevalence	22	12.63; (8–19.4)	26.58	15.27; (9.9–22.1)
Active prevalence	8	4.59 (2–9.1)	9.66	5.55 (2.8–10.6)	4.80 (2–8.1)	5.79 (2.8–10.6)